Abstract Mtgratton of vascular smooth muscle cells (VSMCs) 1s a crucial response to vascular mjury resulting m neomtima formatton and atherosclerosis Platelet-derived growth factor (PDGF-BB) functions as a potent chemoattractant for VSMCs and enhances these pathologies m the vasculature. However, little is known about the mtracellular pathways that mediate VSMC mtgratton In the present study, we mvestigated the role of mltogen-achvated protein kmase (MAPK) activatton m this function, since PDGF-BB as well as other growth factors activate this pathway Usmg an m-gel kmase assay, we observed that PD 98059, an mhlbttor of MEK that activates MAP kmase, inhibited PDGF-BB-induced activation of ERK-1 and ERK-2 m cultured rat aorttc smooth muscle cells m a concentration-dependent manner In contrast, PDGF-mediated acttvation of mtracellular calcmm release was not affected by PD 98059 The chemotacttc response of both rat aorttc smooth muscle cells (RASMCs) and human umbilical vem smooth muscle cells (HUSMCs) toward PDGF-BB (10 ng/mL) was stgmticantly reduced by PD 98059 (10 pmol/L) to 41 7?7 1% m RASMCs (P<.Ol) and to 47 2 (1) increased mtracellular calcmm and the activation of calcmm/calmodulm-dependent protein kmase II', (2) mcreased phosphattdylinosttol turnover linked to the acttvatton of phosphohpase Cy or phospholipase Cp3, (3) actrvatron of phosphatidylmosuol3-kmase4; and (4) activation of RAS and RAF 8 The mrtogenic stgnalmg pathway for PDGF involves the activation of RAS, which activates the serme threonme kmase RAF, which triggers a protein kmase cascade.9 The signal for prohferatton 1s transmitted into the nucleus though the actrvatton of MAPK, which phosphorylates transcription factors that induce expresston of c-fos and other early growth response genes. The involvement of the RAS-RAF-MAPK cascade m cell migration 1s controverstal In fibroblasts expressing a dominant negative RAS, directed migration toward PDGF was suppressed,* suggesting this pathway contributed to cell migration In contrast, IGF-I and PDGF-BB were shown to equally induce VSMC migration, but IGF-1 only weakly mduced MAPK m contrast to PDGF 3 The authors concluded that actrvatron of MAPK may not required for VSMC migration The avatlabrlity of the MEK mhtbrtor PD 98059, which is widely used as a pharmacologrcal mhibttor of the MAPK pathway, and antisense ODN against MAPK mRNA now provides cnttcal tools to determine the specific role of MAPK activation m cell functions such as migration 
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Kristof Graf, Xtao-Ping Xi, Dong Yang, Eckart Fleck, Wtlla A. Hsueh, Ronald E Law Abstract Mtgratton of vascular smooth muscle cells (VSMCs) 1s a crucial response to vascular mjury resulting m neomtima formatton and atherosclerosis Platelet-derived growth factor (PDGF-BB) functions as a potent chemoattractant for VSMCs and enhances these pathologies m the vasculature. However, little is known about the mtracellular pathways that mediate VSMC mtgratton In the present study, we mvestigated the role of mltogen-achvated protein kmase (MAPK) activatton m this function, since PDGF-BB as well as other growth factors activate this pathway Usmg an m-gel kmase assay, we observed that PD 98059, an mhlbttor of MEK that activates MAP kmase, inhibited PDGF-BB-induced activation of ERK-1 and ERK-2 m cultured rat aorttc smooth muscle cells m a concentration-dependent manner In contrast, PDGF-mediated acttvation of mtracellular calcmm release was not affected by PD 98059 The chemotacttc response of both rat aorttc smooth muscle cells (RASMCs) and human umbilical vem smooth muscle cells (HUSMCs) toward PDGF-BB (10 ng/mL) was stgmticantly reduced by PD 98059 (10 pmol/L) to 41 7?7 1% m RASMCs (P<.Ol) and to 47 2 +5 3% m HUSMCs (P< 01) Similar mhibitton was seen at 30 pmol/L, less at 1 pmol/L To further confirm the speclfictty of these results tmplmatmg the MAPK pathway, an anttsense oltgodeoxynucleotlde (ODN) directed against the mlttatton translation site of rat ERK-1 and ERK-2 mRNA was used to suppress MAP kmase synthesis and function m rat VSMCs Ltposomal transfectton with 0 4 pmol/L antisense ODN reduced ERK-1 and ERK-2 protein by 65% (P< 01) after 48 hours The chemotacttc response to PDGF-BB (10 ng/mL) was reduced by 75% (P< 01) m rat VSMCs transfected wttb the same anttsense ODN concentration Sense and scrambled control ODNs (0 4 pmol/L) did not affect ERK-1 and ERK-2 protein concentrattons or chemotaxts of VSMCs induced by PDGF-BB These expenments provide the first evidence that activation of MAPK is a cntma1 event m PDGF-mediated signal transduction regulating VSMC migration (Hypertenswn. 1997; 29[part 2]:334-339.) Key Words l smooth muscle cell migration l plateletderived growth factor l MAP kmase l anttsense ohgodeoxynucleottde A ccumulatton of VSMCs and formation of connective tissue matrix are critrcal events m the development of both restenosrs and atherosclerosis. The accumulation of VSMCs m the mttma results from both cell proliferation and directed mrgratron of VSMCs from the media into the intrma r*zThese processes are regulated by several growth factors that may be released by cells wrthm the Inlured vessel or from ctrculatmg cells PDGF 1s a potent chemoattractant mducmg directed migration of VSMcs.3~4 The importance of PDGF is underscored by studies in the rat balloon inlury model resulting m arterial mtrmal hyperplasra, m which PDGF has been shown to be required for accumulation of VSMCs m the intima due to migration.5~6 Intracellular signalmg pathways controllmg cell mlgratton are poorly understood m comparison to our extensive knowledge of mrtogemc signal transduction Stgnalmg proteins and second messengers tmplmated m (1) increased mtracellular calcmm and the activation of calcmm/calmodulm-dependent protein kmase II', (2) mcreased phosphattdylinosttol turnover linked to the acttvatton of phosphohpase Cy or phospholipase Cp3, (3) actrvatron of phosphatidylmosuol3-kmase4; and (4) activation of RAS and RAF 8 The mrtogenic stgnalmg pathway for PDGF involves the activation of RAS, which activates the serme threonme kmase RAF, which triggers a protein kmase cascade.9 The signal for prohferatton 1s transmitted into the nucleus though the actrvatton of MAPK, which phosphorylates transcription factors that induce expresston of c-fos and other early growth response genes. Rat aortic smooth muscle cells were prepared from thoracic aorta of 2-to 3-month-old Sprague-Dawley rats usmg the explant technique 10 Rats were handled as described previously 11 The cells were cultured m DMEM contammg 10% FBS, 150 mmol/L HEPES, 100 U/mL pemcillm, 100 pg/mL streptomycm, and 200 mmol/L glutatnme The punty and identity of the smooth muscle cell cultures were verified by usmg a monoclonal antibody against smooth muscle a-actin. For all experiments, earlypassaged (54) rat VSMCs were grown to 60% to 70% confluence and made quiescent by serum starvation (0 4%) for at least 16 hours, when MAPK activity was assayed When used, PD 98059 was added 30 mmutes before the addition of growth factors. For all data shown, each mdivldual experiment represented by the n value was performed using an independent preparation of VSMCs Human smooth muscle cells were prepared from human umbilical cords by preparation of the umbihcal vem using the explant techmque. lo Human material was obtained with the adrmnlstrative approval of the institutional review board When required, informed consent was obtained from patients who provided material Cells were cultured m DMEM culture medium as described above Cells from passages 4 to 7 were used for chemotaxis experiments MAPK In-Gel Kinase Assay MAPK activity was measured by the m-gel kmase assay 11 Cells were lysed m a buffer containing 50 mmol/L so&urn pyrophosphate, 50 mmol/L NaF, 50 mmol/L NaCl, 5 mmol/L EDTA, 5 mmol/L EGTA, 100 pmol/L Na3V0,,, 10 mmol/L HEPES, pH 7 4,0 1% Tnton X-100,500 pmol/L PMSF, and 10 hg/mL leupeptm, then flash-frozen on a dry ice/ethanol bath After the cells were allowed to thaw, they were scraped off the dish and centrifuged at 14 000 rpm (4°C for 30 minutes), and protein concentrations were determined usmg the Bradford protein assay (BloRad) Equal amounts of protems (5 to 10 pg) were separated by SDS-PAGE through a gel contammg 0 4 mglmL myehn basic protein The gel was then mcubated twice m buffer A (50 mmol/L HEPES, pH 7.4, and 5 mmol/L ,&mercaptoethanol) contaming 20% isopropyl alcohol for 30 minutes, once m buffer A for 1 hour, twice m buffer A containing 6 mol/L guamdme HCl for 30 minutes, twice m buffer A containing 0 04% Tween 20 at 4°C for 16 and 2 hours; and once m buffer A containing 100 pmol/L Na3V04, 50 bmol/L ATP, and 50 ~0 [g3'P]ATP for 1 hour at 30°C. The reaction was terminated by washing the gel five to eight times m fixative solution containing 10 mmol/L sodmm pyrophosphate and 5% trlchloroacetic acid for 15 minutes. The gel was dried and subJected to autorachography
Migration
Chemotaxis experiments were performed as described prevlously. 11 VSMC migration was examined in transwell cell-culture chambers usmg a gelatin-coated polycarbonate membrane with 8-,um pores. Preconfluent smooth muscle cells were suspended m DMEM/O 4% FBS to a concentration of 5.0X105 cells/ml Cells were pretreated with PD 98059 (1 to 30 pmol/L) or vehicle for 30 minutes at 20°C. DMEM/O 4% FCS (0.6 mL) was added to the lower compartment A 0 I-mL cell suspension (final concenhation' 50 000 cells/well, diameter 6 5 mm) was added to the upper compartment, and cells were then incubated at 37°C (95% sir/5% CO,) Chemotaxis was induced by addition of PDGF-BB m a final concentration of 10 ng/mL to the lower compartment After 4 hours, the filters were fixed with methanol (10 minutes at 4"C), followed by counterstunmg with hematoxyhn The number of VSMCs per 320X high-power field that migrated to the lower surface of the filters was determined microscopically Four to SIX randomly chosen high-power fields were counted per filter Experiments were performed m duplicate or tnpllcate and were repeated at least three times
Liposomal Transfection With Antisense ODN
The antlsense phosphorothioate-modified ODN was a 17-mer (5'-GCCGCCGCCGCCGCCAT-3') directed against the mmatlon of translation site of rat ERK-1 and ERK-2, which have the identical sequence at this site. 12 This ODN has been used successfully to downregulate MAPK expression m rat cardiac myocytesl3 and m 3T3 cells.12 Sense (5'-ATGGCGGCGGCGG CGGC-3') and scrambled controls (5'-CGCGCGCTCGCG CACCC-3') were used All ODNs were synthesized at the Microsequencing Core facility of the University of Southern California using an automated DNA synthesizer (Applied Biosystems, Perkm Elmer) The ODNs were purified on ohgopurification cartridges (Applied Biosystems), dried, and resuspended m sterile water Transfection with ODNs was performed m DMEM/serum-free medium with hpofectm at a final concentration of 10 pg/mL for 6 hours at 37°C Medium was then replaced with hpofectm-free DMEM/2% FBS containing the ongmal ODN concentration, and incubation was allowed to proceed further for 42 hours at 37°C. For migration expenments, 100 000 cells were placed mto the upper compartment of gelatin-coated transwell chambers m DMEM/lO% FBS 20 hours before transfection Transfectron was performed for 48 hours and migration was induced by addition of PDGF-BB to the lower compartment.
Immunoblotting
Cells were washed twice with Ice-cold PBS and lysed with the same buffer as used m the m-gel kmase assay. Equal amounts of proteins (15 pg) were separated by SDS-PAGE and transferred to mtrocellulose membranes usmg a Blo-Rad transblotter Nonspecific bmchng was blocked by using 5% fat-free milk powder. The membrane was incubated with a mouse monoclonal an&ERKl antibody (1 pg/mL), which also recognizes ERK-2, for 1 hour m blocking solution Blots were washed and incubated for another hour with a goat anti-rabbit horseradish-conjugated antibody (1:500, Amersham Life Sclence Inc) before final development usmg the ECL Detection System (Amersham) Cell Ca2+ Measurement Confluent VSMC monolayers were starved in serum-free medium for 24 hours at 37°C Cells were trypsmlzed (0 25% trypsm, 1 mmolk EDTA; Gibco) briefly and cell suspensions were washed once with HBKM (107 mmolk NaCl, 6 mmol/L KCl, 1.2 mmol/L MgS04, 1 mmol/L CaCl*, 1.2 mmolk K&PO,, 11.5 mmol/L glucose, 20 mmol/L HEPES, pH 7.4). Cells were incubated with 5 mmol/L Fura-2-Am (Molecular Probes Inc) in HBKM containing 1% BSA for 30 minutes. Then cells were washed twice with HBKM to remove excess dye. Before measurement of cell Ca2+, cells were pretreated with PD 98059 for 45 minutes. One milliliter of cell suspension was transferred to cuvettes and stirred continuously with a magnetic stir bar with constant temperature of 37°C. Fluorescence was detected with a fluorescence spectrophotometer (Hitachi F-200) at excitation wavelengths of 340 nm and 380 nm and an emission wavelength of 510 nm. PDGF-BB was added to induce intracellular Ca*+ release after starting the experiment. Intracellular Ca*' concentrations were estimated by calibration of the intracellular Ca*+ signal. Cells were lysed with 0.02% Triton-X100 to achieve 100% saturation of the dye, whereas minimal fluorescence was determined with 4 mmol/L EGTA, 30 mmol/L Tris, K,=224 nm, as described previously.14 tion was observed at 0.7 PmollL for ERK-1 and at 4 pmol/L for ERK-2 in rat VSMCs.
PD 98059 Inhibits PDGF-BB-Mediated
Migration in Rat and Human VSMCs
Statistics
Migration experiments with VSMCs were performed using two different protocols. In the first protocol, cells were treated with PD 98059 or vehicle for 30 minutes and were added afterward to the upper compartment of the modified Boyden chamber. Chemotaxis was induced by addition of PDGF-BB to the lower compartment. PDGF-BB (10 ng/mL) induced a 5.0+0.6-fold increase of migrated cells (P<.Ol versus control, n=6) compared with control. This effect was significantly reduced to a 2.3t0. ANOVA and paired or unpaired 1 tests were performed for statistical analysis as appropriate. A value of P<.O5% was considered to be statistically significant. Data are expressed as mean+SEM.
Results

PD 98059 Inhibits MAPK Activation by PDGF-BB
Rat aortic VSMCs were made quiescent by 16-hour treatment in 0.4% serum. Quiescent VSMCs exhibited low MAPK activity, as evidenced by the faint signals produced -by the phosphorylation of myelin basic protein by p44 (ERK 1) and p42 (ERK 2) in the in-gel kinase assay (Fig lA, lane 1) . Strong induction of ERK 1 (=l&fold) and ERK 2 activity (x5-fold) was observed after lo-minute treatment with PDGF-BB, a potent chemoattractant for VSMCs (Fig 1A and 1B) . PDGF-BB-induced MAPK activation was inhibited in a concentration-dependent manner by PD 98059, a synthetic inhibitor of MEK, a dual specific kinase that activates both ERK-1 and ERK-2 by phosphorylation at specific threonine and tyrosine residues (Fig 1A) . PD 98059 at 1 PmollL inhibited the PDGF-induced activation of ERK-1 by 62.4t7.9% and of ERK-2 by 45.3-~9.7% in rat VSMCs (n=4; P<.Ol versus PDGF alone). At the maximal tested concentration of 30 pmol/L PD 98059, PDGF-induced ERK-1 and ERK-2 activity declined nearly to the baseline MAPK activity seen in quiescent cells (Fig 1B) . Half-maximal inhibiTo distinguish between a possible effect of PD 98059 on adhesion of VSMCs to the gelatin-coated membranes and a subsequent inhibition of chemotaxis, cells were added to the upper compartment and treatment with PD 98059 was initiated after a delay of 60 minutes in the second protocol. In adhesion experiments using gelatin-coated membranes, we have observed that the adhesion by rat aortic smooth muscle cells is maximally achieved after 40 to 45 minutes at 37°C (data not shown). After 45 minutes' incubation with the MEK inhibitor, PDGF-BB was added to the lower compartment and migration was stopped 4 hours later. PDGF-BB (10 ng/mL) induced a 4.5rt0.5-fold increase in migrated cells (P<.Ol versus control), which was already diminished by 1 pmol/L PD compound to 2.1-+0.2-fold (P<.Ol versus PDGF alone). At higher concentrations, the MEK inhibitor completely abolished the PDGF-induced migration (Fig 2A) . PD 98059 (30 pmol/L) alone had no effect on unstimulated cells.
We performed parallel experiments with VSMCs obtained from human umbilical veins. In human vascular smooth muscle cells, PD 98059 was also able to block PDGF-directed migration nearly completely at 10 and 30 pmol/L (Fig 2B) . PD 98059 (1 pmol/L) was less effective in diminishing PDGF-mediated migration in human VSMCs than in rat VSMCs. The MEK inhibitor PD 98059 was effective in preventing PDGF-mediated migration with a half-maximal inhibition observed at 0.9 pmol/L for rat VSMCs and 4.8 pmol/L for human VSMCs. 
PD 98059 Does Not Affect Intracellular Ca2+
Release by PDGF-BB PDGF-BB (10 ng/mL) induced a rapid increase in intracellular calcium concentrations that was not significantly altered by pretreatment with PD 98059 for 45 minutes. The absorbances were as follows: PDGF 10 ng/mL, 285.4t 48.6 nm; PDGF plus 1 pmol/L PD 98059,265.6?25.7 nm; PDGF plus 10 p,mol/L PD 98059, 265.7219.0 nm; and PDGF plus 30 pmol/L PD 98059,236? 13.1 nm (the latter was nonsignificant versus PDGF alone; results shown are mea&SD from three different experiments).
Antisense ODN Against MAPK mRNA Downregulates MAPK Protein and Inhibits PDGF-Mediated Migration To further establish the crucial role of MAPK activation in PDGF-BB-directed migration, we performed antisense experiments using a 17-mer ODN targeting the initiation site for ERK 1 and ERK 2 mRNA. LipoGraf et al MAP Kinase and VSMC Migration 337 somal transfection with the antisense ODN for 48 hours induced a concentration-dependent suppression of ERK-1 and ERK-2 protein levels (Fig 3) . At a concentration of 0.4 pmol/L, MAPK protein was reduced by 65% (P<.Ol). Lipofectin alone or control ODNs, both sense and scrambled at identical concentrations to antisense, did not affect ERK-1 and ERK-2 protein concentrations (Fig 3) .
Liposomal transfection of rat VSMCs with the MAPK antisense ODNs also attenuated PDGF-mediated migration. After 48 hours of transfection, the migratory response of rat VSMCs was reduced by 75% with 0.4 pmol/L antisense ODN and by 40% in the presence of 0.1 pmol/L antisense ODN (both P<.O5 versus control and lipofectin).
Liposomal transfection alone and with control ODNs did not significantly alter the migratory response of rat VSMCs to PDGF-BB (Fig 4) .
Discussion
The present investigation provides strong evidence for the involvement of the MAPK signaling pathway in PDGF-mediated migration of VSMCs. PDGF-BB is a potent activator of the MAPK pathway by triggering RAS-RAF activation, which activates MEK, which then phosphorylates ERK-1 and ERK-2 in VSMCs. In the present study, PDGF-BB induced a 5-fold increase of ERK-1 and an 1 g-fold increase of ERK-2 activity after 10 minutes. A synthetic inhibitor of the ERK pathway, PD 98059, demonstrated a concentration-dependent inhibitory effect on PDGF-induced MAPK activation in VSMCs. The halfmaximal inhibitory concentrations measured in our system were similar to those observed to inhibit MAPK activation and growth in 3T3 fibroblastsrs and in VSMCs.16 PD 98059 also demonstrated a concentration-dependent inhibition on PDGF-BB-mediated migration in both rat and human VSMCs. The half-maximal inhibitory concentrations to inhibit migration were in the same range that inhibited MAPK activity in our in-gel kinase assay. The specific inhibition of MAPK activation using antisense ODNs against ERK-1 and ERK-2 mRNA suppressed MAPK protein expression and inhibited PDGF-mediated migration of VSMCs toward PDGF-BB. The sense and scrambled control ODNs had no effect on MAPK expression or PDGFmediated migration. These data provide more conclusive proof that the MAPK pathway plays an important role in PDGF-induced migration of human and rat VSMCs.
Transfection of VSMCs with plasmid DNA occurs with low efficiency. In contrast, ODNs complexed with liposomes transfect VSMCs at high efficiency. A recent study by Pickering et al'7 using fluorescein-tagged ODNs revealed that virtually all VSMCs treated with as little as 0.2 pmol/L for 1 hour incorporated the ODNs into both the nucleus and the cytoplasmic compartment. A similar high efficiency of transfection can be inferred from our results showing that MAPK protein levels were specifically depleted to 35% of the levels in VSMCs treated with sense and scrambled ODNs (Fig 3) .
Previous investigations aimed at identifying whether the MAPK pathway mediates cell migration are inconclusive. migrate toward PDGF-BB. Moreover, if the cells constitutively expressed RAF, the step immediately downstream from RAS, there was no effect on migration toward PDGF-BB. The authors proposed that an unknown alternate pathway distal to RAS, but not involving RAF, was responsible for cell migration and that too little or too much RAS activity could inhibit migration. These findings are not necessarily inconsistent with ours. All of their findings are compatible with a mechanism for chemotactic signaling in which cells can transition from a ground level, or unstimulated state, to an induced state as they respond to gra- Bornfeldt and colleagues3 investigated migration of human VSMCs toward IGF-1 and PDGF-BB and found that both growth factors increased phosphoinositol turnover and calcium flux. They found that only PDGF-BB induced MAPK activation and concluded that MAPK activation is not required for chemotaxis signaling. However, their study did not address whether inhibition of MAPK activation had any effect on PDGF-mediated migration. Furthermore, activation of the MAPK pathway by both insulin and IGF-1 has been observed in our laboratory (R.E.L., unpublished data, 1996) for VSMCs and reported by other groups for several other cell types.'*J9 Another essential step in the intracellular pathway mediating chemotaxis upstream of MEK is the activation of the calcium/calmodulin-dependent protein kinase II, which is normally activated by increased Cazf transients.7 MAPK can be activated through at least two different pathways, one that is dependent on calcium mobilization and one that is calcium independent.20 We therefore tested the effect of PD 98059 on PDGF-induced Ca*+ transients. PDGF induced a strong Ca*+ transient in rat VSMCs that was unaffected in the presence of the PD compound. This finding suggests that increased intracellular calcium levels without a subsequent activation of the MAPK are insufficient for chemotactic signaling.
PD 98059 appears to be a highly selective mhibitor of MEK; it has been shown to have no effect on p70 S6 kmase, phosphohpase C, Raf-kmase, CAMP-dependent ktnase, protein kmase C, v-Src, EGF receptor kmase, the PDGF receptor kmase, and the phosphatidylmosttol 3-hnase. I5 16 1921 However, the possibihty that this synthetic mhibrtor affects other cellular targets cannot be ruled out completely Therefore, we employed antisense ODNs against MAPK to inhibit this pathway Both approaches decreased MAPK activity and mhibited PDGF-directed migration of VSMCs
In this study, we present the first evidence for a potential role of the MAPK pathway m the regulation of chemotaxis toward PDGF-BB gradients m rat and human VSMCs Thus, two important actions of VSMC involved m restenom and atherosclerosis, migration and prohferation, are dependent on the MAPK pathway Approaches designed to inhibit this pathway, therefore, may be useful to prevent or inhibit the progression of this mechanisms m the vasculature. Indeed, we have recently reported that the msulin-sensmzmg drug troghtazone inhibits basic fibroblast growth factor-induced VSMC growth and PDGF-induced migration, mduction of c-fos transcription regulated via MAPK activation, and mtimal hyperplasta resulting from balloon mlury of the rat aorta 11 Whether anttsense against MAPK will have a similar impact m vtvo deserves further investigation
